ESC: Evidence Mounts for Injection to Lower LDL-C (CME/CE)

BARCELONA (MedPage Today) -- Four studies testing the injectable novel lipid-lowering agent alirocumab found the drug dramatically reduced LDL-cholesterol (LDL-C) among high-risk patients who had not achieved LDL targets using maximum tolerated statin therapy and/or ezetimibe. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1pxeZR0